marijuana stocks news

Form 8-K for TWO RIVERS WATER & FARMING CO

21-Nov-2014

Regulation FD Disclosure, Financial Statements and Exhibits

ITEM 7.01 Regulation FD DisclosurePress Release

The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.

Two Rivers Water & Farming Company announced today it has rejected Farmland Partner, Inc.’s offer to purchase and lease back irrigated farmland that Two Rivers owns on the Bessemer Ditch in Pueblo County, Colorado.

The text of the press release is attached herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits(d) Exhibits.The following is a complete list of exhibits filed as part of this Report. Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.

Exhibit No. Description
99.1 Press release dated November 21, 2014* *Filed herewith


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Namaste Technologies Inc. (NXTTF) Signs Product Acquisition Agreement with Weed Me Inc.

Cannmart Signs Product Acquisition Agreement with Weed Me Inc. Namaste Technologies Inc.…

GTEC Holdings Ltd. (GTEC.V) (GGTTF) Announces Incorporation into Horizons Marijuana Life Sciences Index ETF

GTEC Announces Incorporation into Horizons Marijuana Life Sciences Index ETF GTEC Holdings…

$ERBB Board of Directors Selects Miller as CEO

American Green Board of Directors Selects Miller as CEO American Green, Inc.…

$GWPH Initiates Second Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome

GW Pharmaceuticals Initiates Second Phase 3 Pivotal Trial for Epidiolex in Dravet…